Delivery Order SPE2DB22D2206-SPE2DB25FHM43
- Not listed
- The Defense Logistics Agency awarded a $3,437.72 delivery order to AmerisourceBergen Drug Corp for the procurement of Indocyanine Green 25 mg vials. Issued on June 5, 2025, with an ultimate completion date of June 6, 2025, this firm fixed-price contract represents a non-competitive award issued under an existing contract vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Indocyanine Green 25 mg vials, valued at $5,710.82 with a firm fixed price and a completion deadline of June 2, 2025. This is an unset-aside, competitively awarded delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The work will be performed at the contractor's corporate office location in Conshohocken,...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,875.60, is for the supply of Indocyanine Green 25 mg vials, a medical product used in various healthcare applications. The contract has a firm fixed price pricing type and a period of performance through May 8, 2024. Amerisourcebergen is the prime contractor for this Delivery Order and holds a larger...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $5,144.62 firm fixed price contract is for the supply of Indocyanine Green 25 mg vials, with a performance period through April 3, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,230.55, is for the delivery of 4567646317 - Indocyanine Green 25 mg Vials. The contract is a firm fixed-price delivery order with a period of performance through March 21, 2025. No set-aside designation was used for this award. AmerisourceBergen maintains a...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,676.13, is for the delivery of 25 mg vials of Indocyanine Green, a medical product used in various medical procedures. The contract has a completion date of May 15, 2024 and is a firm-fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp...
- This federal contract award, valued at $2,898.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566682345 Indocyanine Green 25 mg vials and has a completion date of December 12, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. No set-aside designation was used for this award. In addition to this specific contract,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Indocyanine Green 25 mg vials, a medical product used in various medical procedures. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,317.71 and a period of performance through April 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,669.64 firm fixed-price delivery order is for the supply of Indocyanine Green 25 mg vials, with a completion date of January 14, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Indocyanine Green 25 mg vials. The contract has a total ceiling value of $6,112.50 and is a firm fixed price delivery order. The ultimate completion date for the contract is September 24, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, will be the prime contractor responsible for providing the...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FHM43Delivery Order
The Defense Logistics Agency awarded a $17,358.35 delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Indocyanine Green 25 mg vials. This contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of June 18, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a leading pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying a comprehensive range of pharmaceuticals and medical supplies to support military and veteran healthcare systems. The IDC vehicle enables the company to efficiently fulfill federal medical supply requirements across multiple therapeutic domains, with delivery orders such as this one issued on an as-needed basis to support ongoing healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.4k | 6/17/25 |